✦ LIBER ✦

High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis

✍ Scribed by Anniella Isgren; Kristina Forslind; Malin Erlandsson; Carl Axelsson; Sofia Andersson; Anneli Lund; Maria Bokarewa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating bioactive TNF in rheumatoid

✍ H Marotte, P Miossec 📂 Article 📅 2003 🏛 BioMed Central 🌐 English ⚖ 595 KB

Regulation of IFN response gene activity

✍ Lisa GM van Baarsen, Carla A Wijbrandts… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 618 KB

Monitoring C-reactive protein levels to

✍ Kojima, Toshihisa; Yabe, Yuichiro; Kaneko, Atsushi; Hirano, Yuji; Ishikawa, Hisa 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 454 KB

Circulating tumour necrosis factor-α bio

✍ Hubert Marotte, Wlodzimierz Maslinski, Pierre Miossec 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 357 KB

B-Cell Activating Factor Levels in Rheum

✍ Pyrpasopoulou, Athina; Balaska, Ekaterini; Triantafyllou, Areti; Anyfanti, Panag 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 101 KB

DAS28 best reflects the physician's clin

✍ Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 308 KB